Skip to main content

Table 2 Outcome of patients with VARI, VAP, other VARI, and no VARI

From: Ventilator-associated respiratory infection in a resource-restricted setting: impact and etiology

  All VARI (n = 92) VAP (n = 37) VARI without VAP (n = 55) No VARI (n = 286)
ICU length of stay (days) 27 (21–37) 25 (19–37) 27 (25–38) 16 (10–28)
Days ventilated (days) 22 (15.5–29.5) 21 (14–28) 22 (17–31) 10 (6–16)
ICU cost (USD) * 4723 (2778–7783) 7213 (3011–8329) 4196 (2726–7193) 2534 (1493–4407)
Hospital length of stay (days) 38 (26–49) 31 (22–46) 39.5 (29.5–49) 25 (14–39)
Hospital cost (USD)** 4434 (2656–7822) 4522 (2716–7990) 4167 (2658–6985) 2639 (1555–4576)
Antibiotics use (DOT) 31 (18–42.5) 35 (21–45) 30 (17–38) 18 (10–28)
Antibiotics in hospital before VARI 73/92 (79.4%) 28/38 (75.6%) 45/55 (87.7%) 255/282 (90.43%)
In-hospital mortality 17/91 (18.7%) 13/37 (35.1%) 4/54 (7.4%) 54/277 (19.5%)
  1. Values given are median (IQR) or count (percent)
  2. * n = 372; ** n = 313